CEO/CFO advisory: Our main role
Business planning: Inputting at key strategic inflection points
Delivery: Complementing your in-house resource
CEO/CFO
Advisory
Experience-based advisory, provided on as needed basis
Extension of your in-house executive team
Responsive and committed; long-term relationship ultimately aiming for clients’ successful exit/growth and wide use of their products in clinics
Quality focus; we serve no more than three clients at any time and our sole purpose is client impact and satisfaction, which ultimately benefits patients
Business planning
Shaped through consultation; typically includes some of the below:
Clinical asset potential and requirements:
Clinical unmet need in key countries, product positioning
Regulatory label and claims (EMA, MHRA, JPMA)
Pricing and reimbursement prospects in key countries
Commercialisation paths; revenue and P/L prospects
Cashflow requirements; ways to modulate cash burn and mitigate risks
Business strategy
Assessment of strategic options: trade-off of reward, risk and cashflow requirement
Decision and communication support
Internal decisions facilitation
Investor communication support
Delivery
Operational delivery
Regulatory: regulatory dossier preparation, regulatory consultations, etc.
Market access: pricing strategy, launch sequencing, dossier preparation, modelling, payor consultations, etc.
Business development: partner candidate outreach, dialogue, selection
Finance: cashflow optimisation, tax planning, investor communication
Commercial: launch plan
Capability building
Introduction of subject matter experts and specialist firms
Recruitment of core staff
Ex-US awareness and knowledge building in the HQs executive team